Tetrabenazine for tardive tremor in elderly adults: A prospective follow-up study

Clinical Neuropharmacology

Volumn 38, Issue 1, 2015, Pages 23-25

  Kertesz, Diana Paleacu ^a,b   Swartz, Marnina Vanetik ^b,c   Tadger, Shelly ^a   Plopski, Igor ^a   Barak, Yoram ^a,b  

^a ABARBANEL MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Open Psychiatry Department   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TETRABENAZINE;

ABNORMAL INVOLUNTARY MOVEMENT SCORE; ADULT; AGED; AKATHISIA; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GERIATRIC DEPRESSION SCORE; HUMAN; MALE; MIDDLE AGED; PARKINSONISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; SEDATION; TARDIVE TREMOR; TREATMENT DURATION; TREMOR; TREMOR SCALE;

EID: 84964065609     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0000000000000061     Document Type: Article

References (15)

1. Min-Jing L, Pao-Yen L, Yung-Ye C, et al. Antipsychotics-induced tardive syndrome: a retrospective epidemiological study. Clin Neuropharmacol 2014;37(4):111-115.
2. Stacy M, Jankovic J. Tardive tremor. Mov Disord 1992;7(1):53-57.
3. Chen JJ, OndoWG, Dashtipour K, et al. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Clin Ther 2012;34(7):1487-1504.
4. Paleacu D, Giladi N, Moore O, et al. Tetrabenazine treatment in movement disorders. Clin Neuropharmacol 2004;27(5):230-233.
5. Delecluse F, Elosegi JA, Gerard JM. A case of tardive tremor successfully treated with clozapine. Mov Disord 1998;5(5):846-847.
6. Storey E, Lloyd J. Tardive tremor. Mov Disord 1997;12(5):808-810.
7. Newel KM, Gao F, Sprague RL. The dynamical structure of tremor in tardive dyskinesia. Chaos 1995;5(1):4347.
8. Tryon WW, Pologe B. Accelerometric assessment of tardive dyskinesia. Am J Psychiatry 1987;144(12):1584-1587.
9. Munetz MR, Benjamin S. How to examine patients using the Abnormal Involuntary Movement Scale. Hosp Commun Psych 1988;39(11): 1172-1177.
10. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol 1986;5(1/2):165-173.
11. Jancovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997;48(2):358-362.
12. Tarsy D, Indorf G. Tardive tremor due to metoclopramide. Mov Disord 2002;17(3):620-621.
13. Huntington Study Group. Tetrabenazine as antichorea therapy in Huntington's disease: a randomized controlled trial. Neurology 2006;66(3): 366-372.
14. Kenney C, Hunter C, Mejia N, et al. Is history of depression a contraindication to treatment with tetrabenazine? Clin Neuropharmacol 2006;29(5):259-264.
15. Swash M, Roberts AH, Zakko H, et al. Treatment of involuntary movement disorders with tetrabenazine. J Neurol Neurosurg Psychiatry 1972;35(2): 186-191.